Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NK2R antagonists(Neurokinin 2 receptor antagonists), NK3 antagonists(Neurokinin 3 receptor antagonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC34H44N4O2 |
InChIKeyNJYXPRQYHXQQOR-VWLOTQADSA-N |
CAS Registry270573-43-8 |